학술논문
923TiP - A phase 2 BIOmarker driven trial with Nivolumab and Ipilimumab or VEGFR tKi in naïve metastatic Kidney cancer: the BIONIKK trial
Document Type
Abstract
Source
In Annals of Oncology September 2017 28 Supplement 5:v327-v327
Subject
Language
ISSN
0923-7534